Document is current
Any future updates will be listed below
-
Authors
Hossenbaccus, Lubnaa
Linton, Sophia
Thiele, Jenny
Steacy, Lisa
Walker, Terry
Malone, Crystal
Ellis, Anne K. http://orcid.org/0000-0002-0725-2353
- License Information
-
More Information
Article History
Received: 15 December 2020
Accepted: 13 March 2021
First Online: 26 March 2021
Declarations
:
: This study was reviewed, and ethics clearance granted by the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (DMED-1914–16). All participants reviewed and provided signed consent prior to study enrollment.
: Participants provided such consent as part of the informed consent form.
: AKE has participated in advisory boards for ALK-Abelló, AstraZeneca, Aralez, Bausch Health, Circassia Ltd, GlaxoSmithKline, LEO Pharma, Johnson & Johnson, Merck, Mylan, Novartis, Pediapharm and Pfizer, has been a speaker for ALK, Aralez, AstraZeneca, Boerhinger-Ingelheim, CACME, Meda, Mylan, Merck, Novartis, Pediapharm, Pfizer, The ACADEMY, and Takeda. Her institution has received research grants from Bayer LLC, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Sun Pharma, Merck, Novartis, Pfizer, Regeneron and Sanofi. She has also served as an independent consultant to Allergy Therapeutics, Bayer LLC, Ora Inc. and Regeneron in the past.
